Immunome (NASDAQ:IMNM) reported its Q4 earnings results on Tuesday, March 3, 2026 at 04:02 PM.
Here’s what investors need to know about the announcement.
Earnings
Immunome missed estimated earnings by -25.0%, reporting an EPS of $-0.75 versus an estimate of $-0.6.
Revenue was down $2.74 million from the same period last year.
Previous Earnings Records
In the previous quarter, the company missed on EPS by …